Price disclosure 2021 October cycle outcomes summary


23 June 2021 - The summary of price disclosure price reductions for the 2021 October cycle has now been published.

The following medicines are scheduled to incur a 30% price reduction:

  • Azacitidine
  • Imatinib mesylate
  • Sildenafil citrate
  • Tobramycin

Read PBS News

Michael Wonder

Posted by:

Michael Wonder